These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 11179722)
1. Different shapes of the steroid hormone 1alpha,25(OH)(2)-vitamin D(3) act as agonists for two different receptors in the vitamin D endocrine system to mediate genomic and rapid responses. Norman AW; Henry HL; Bishop JE; Song XD; Bula C; Okamura WH Steroids; 2001; 66(3-5):147-58. PubMed ID: 11179722 [TBL] [Abstract][Full Text] [Related]
2. Molecular tools for study of genomic and rapid signal transduction responses initiated by 1 alpha,25(OH)(2)-vitamin D(3). Norman AW; Bishop JE; Bula CM; Olivera CJ; Mizwicki MT; Zanello LP; Ishida H; Okamura WH Steroids; 2002 May; 67(6):457-66. PubMed ID: 11960621 [TBL] [Abstract][Full Text] [Related]
3. Update on biological actions of 1alpha,25(OH)2-vitamin D3 (rapid effects) and 24R,25(OH)2-vitamin D3. Norman AW; Okamura WH; Bishop JE; Henry HL Mol Cell Endocrinol; 2002 Nov; 197(1-2):1-13. PubMed ID: 12431790 [TBL] [Abstract][Full Text] [Related]
4. Ligands for the vitamin D endocrine system: different shapes function as agonists and antagonists for genomic and rapid response receptors or as a ligand for the plasma vitamin D binding protein. Norman AW; Ishizuka S; Okamura WH J Steroid Biochem Mol Biol; 2001; 76(1-5):49-59. PubMed ID: 11384863 [TBL] [Abstract][Full Text] [Related]
5. Minireview: vitamin D receptor: new assignments for an already busy receptor. Norman AW Endocrinology; 2006 Dec; 147(12):5542-8. PubMed ID: 16946007 [TBL] [Abstract][Full Text] [Related]
6. Vitamin D receptor (VDR)-mediated actions of 1α,25(OH)₂vitamin D₃: genomic and non-genomic mechanisms. Haussler MR; Jurutka PW; Mizwicki M; Norman AW Best Pract Res Clin Endocrinol Metab; 2011 Aug; 25(4):543-59. PubMed ID: 21872797 [TBL] [Abstract][Full Text] [Related]
7. Nongenotropic, anti-apoptotic signaling of 1alpha,25(OH)2-vitamin D3 and analogs through the ligand binding domain of the vitamin D receptor in osteoblasts and osteocytes. Mediation by Src, phosphatidylinositol 3-, and JNK kinases. Vertino AM; Bula CM; Chen JR; Almeida M; Han L; Bellido T; Kousteni S; Norman AW; Manolagas SC J Biol Chem; 2005 Apr; 280(14):14130-7. PubMed ID: 15671029 [TBL] [Abstract][Full Text] [Related]
8. Comparison of 6-s-cis- and 6-s-trans-locked analogs of 1alpha,25-dihydroxyvitamin D3 indicates that the 6-s-cis conformation is preferred for rapid nongenomic biological responses and that neither 6-s-cis- nor 6-s-trans-locked analogs are preferred for genomic biological responses. Norman AW; Okamura WH; Hammond MW; Bishop JE; Dormanen MC; Bouillon R; van Baelen H; Ridall AL; Daane E; Khoury R; Farach-Carson MC Mol Endocrinol; 1997 Sep; 11(10):1518-31. PubMed ID: 9280067 [TBL] [Abstract][Full Text] [Related]
9. Rapid and genomic biological responses are mediated by different shapes of the agonist steroid hormone, 1alpha,25(OH)2vitamin D3. Norman AW; Song X; Zanello L; Bula C; Okamura WH Steroids; 1999; 64(1-2):120-8. PubMed ID: 10323680 [TBL] [Abstract][Full Text] [Related]
10. Natural metabolites of 1alpha,25-dihydroxyvitamin D(3) retain biologic activity mediated through the vitamin D receptor. Harant H; Spinner D; Reddy GS; Lindley IJ J Cell Biochem; 2000 Apr; 78(1):112-20. PubMed ID: 10797570 [TBL] [Abstract][Full Text] [Related]
11. Membrane actions of vitamin D metabolites 1alpha,25(OH)2D3 and 24R,25(OH)2D3 are retained in growth plate cartilage cells from vitamin D receptor knockout mice. Boyan BD; Sylvia VL; McKinney N; Schwartz Z J Cell Biochem; 2003 Dec; 90(6):1207-23. PubMed ID: 14635194 [TBL] [Abstract][Full Text] [Related]
12. Characterization of five 19-nor-analogs of 1alpha,25(OH)2-Vitamin D3 with 20-cyclopropyl-modified side-chains: implications for ligand binding and calcemic properties. Olivera CJ; Bula CM; Bishop JE; Adorini L; Manchand P; Uskokovic MR; Norman AW J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):99-106. PubMed ID: 15225754 [TBL] [Abstract][Full Text] [Related]
13. Temporal changes in tissue 1α,25-dihydroxyvitamin D3, vitamin D receptor target genes, and calcium and PTH levels after 1,25(OH)2D3 treatment in mice. Chow EC; Quach HP; Vieth R; Pang KS Am J Physiol Endocrinol Metab; 2013 May; 304(9):E977-89. PubMed ID: 23482451 [TBL] [Abstract][Full Text] [Related]
14. Differing shapes of 1 alpha,25-dihydroxyvitamin D3 function as ligands for the D-binding protein, nuclear receptor and membrane receptor: a status report. Norman AW; Bishop JE; Collins ED; Seo EG; Satchell DP; Dormanen MC; Zanello SB; Farach-Carson MC; Bouillon R; Okamura WH J Steroid Biochem Mol Biol; 1996 Jan; 56(1-6 Spec No):13-22. PubMed ID: 8603033 [TBL] [Abstract][Full Text] [Related]
15. A specific binding protein/receptor for 1alpha,25-dihydroxyvitamin D(3) is present in an intestinal caveolae membrane fraction. Norman AW; Olivera CJ; Barreto Silva FR; Bishop JE Biochem Biophys Res Commun; 2002 Nov; 298(3):414-9. PubMed ID: 12413957 [TBL] [Abstract][Full Text] [Related]
16. Molecular basis of the selective activity of vitamin D analogues. Carlberg C J Cell Biochem; 2003 Feb; 88(2):274-81. PubMed ID: 12520526 [TBL] [Abstract][Full Text] [Related]
17. Plasma membrane requirements for 1alpha,25(OH)2D3 dependent PKC signaling in chondrocytes and osteoblasts. Boyan BD; Wang L; Wong KL; Jo H; Schwartz Z Steroids; 2006 Apr; 71(4):286-90. PubMed ID: 16325216 [TBL] [Abstract][Full Text] [Related]
18. Applications of the Vitamin D sterol-Vitamin D receptor (VDR) conformational ensemble model. Mizwicki MT; Bishop JE; Norman AW Steroids; 2005; 70(5-7):464-71. PubMed ID: 15862832 [TBL] [Abstract][Full Text] [Related]
19. 1,25(OH)2-vitamin D3, a steroid hormone that produces biologic effects via both genomic and nongenomic pathways. Norman AW; Nemere I; Zhou LX; Bishop JE; Lowe KE; Maiyar AC; Collins ED; Taoka T; Sergeev I; Farach-Carson MC J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):231-40. PubMed ID: 1314073 [TBL] [Abstract][Full Text] [Related]
20. The vitamin D hormone and its nuclear receptor: molecular actions and disease states. Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]